Enovis Corporation ENOV

Company Overview

Enovis Corporation (NYSE: ENOV) is a U.S.-based medical technology company focused on orthopedic and reconstructive care solutions. The company develops, manufactures, and markets products used in orthopedic reconstruction, surgical technologies, rehabilitation, pain management, and prevention. Enovis operates primarily within the global medical devices and healthcare technology industries, serving hospitals, ambulatory surgery centers, orthopedic surgeons, rehabilitation providers, and patients. Its core revenue drivers include reconstructive implant systems, orthopedic surgical technologies, and patient recovery products used across hip, knee, shoulder, foot, ankle, and spine-related procedures.

The company traces its roots to Colfax Corporation, an industrial manufacturing business founded in 1995. In 2022, Colfax officially rebranded as Enovis Corporation following the separation and sale of several industrial operations and a strategic transition toward becoming a pure-play medical technology company. A major catalyst in this transformation was the acquisition of DJO Global, which significantly expanded Enovis’ orthopedic and rehabilitation portfolio. The company positions itself around an “Intelligent Motion” strategy that integrates implants, surgical technologies, and recovery solutions intended to improve patient outcomes and procedural efficiency.